This pathology case study focuses on the differential diagnosis of a large (15 cm) retroperitoneal mass in a 50-year-old male, characterized by the presence of numerous pleomorphic lipoblasts. The core diagnostic challenge is distinguishing between Pleomorphic Liposarcoma, Dedifferentiated Liposarcoma (DDLPS), and Well-Differentiated Liposarcoma (WDLPS). The presenter ultimately diagnoses the lesion as an unusually "exuberant" WDLPS, based on its hypocellularity, abundant mature fat component, and low mitotic activity, which outweighs the high degree of cytologic atypia. A key diagnostic technique emphasized is assessing whether the underlying background stroma resembles a high-grade sarcoma after mentally excluding the scattered atypical cells. The video concludes by confirming the expected molecular signature for WDLPS: MDM2 amplification.
Pathology Summary: Diagnosis of a Retroperitoneal Liposarcoma
0:00 Case Presentation: The case involves a 50-year-old male presenting with a 15-centimeter retroperitoneal mass.
0:11 Defining the Lipoblast: Pleomorphic lipoblasts are defined by a big, ugly pleomorphic nucleus and clear, perfectly round, sharply circumscribed lipid vacuoles (lipid droplets that wash out during processing), which typically scale up and push against the nucleus.
0:44 Diagnostic Challenge: The main difficulty is differentiating the mass, which contains pleomorphic lipoblasts, from Pleomorphic Liposarcoma, Dedifferentiated Liposarcoma (DDLPS), and Well-Differentiated Liposarcoma (WDLPS).
1:00 Rationale for WDLPS: This case is identified as an "exuberant" WDLPS because, despite having very big, ugly pleomorphic lipoblasts, the lesion is overall hypocellular, contains a significant amount of mixed mature fat, and exhibits relatively low mitotic activity.
1:22 DDLPS Distinction: DDLPS usually looks like a high-grade pleomorphic spindle cell sarcoma (undifferentiated), typically appearing adjacent to a well-differentiated component, and surprisingly often lacks lipoblasts.
2:18 Key Diagnostic Filter: A critical test for confirming WDLPS is to mentally remove the scattered atypical cells and lipoblasts. If the background remaining tissue does not resemble a high-grade sarcoma, the diagnosis leans toward WDLPS.
2:52 Molecular Confirmation: The expected molecular abnormality for WDLPS is MDM2 amplification, often seen with co-amplification of other genes like CDK4. This is commonly tested using FISH (Fluorescence In Situ Hybridization) or immunostains.